Birdwatch Archive

Birdwatch Note

2024-10-10 14:20:48 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

世界でも抗がん剤は沢山使われています https://news.yahoo.co.jp/expert/articles/1b191a2ed5889e97d4311826f130aa016629b2a8 https://answers.ten-navi.com/pharmanews/16470/ https://www.who.int/europe/news-room/fact-sheets/item/cancer-treatment 日本の年齢調整死亡率は減少しておりG7の中でも最も優秀です https://data.oecd.org/chart/7hLT https://data.oecd.org/healthstat/deaths-from-cancer.htm 米国国立がん研究所所長(当時)DeVita氏は、がん死亡減少の半分の原因は主に化学療法を含むがん治療の進歩によるとしています https://doi.org/10.1158/0008-5472.CAN-07-6611 https://en.wikipedia.org/wiki/Vincent_T._DeVita 科学的根拠に基づかない主張の目的は偽医療への誘導です。 日本人が欧米事情等に疎いことは昔から偽医療利権に悪用されます https://youtu.be/nySPY7eH9IU https://cancer.jpn.org/static/fake_medicine.html https://cancer.jpn.org/static/ota_h_405_unconventional_cancer_treatments.html 代替医療にがんの治療効果はありません https://doi.org/10.1093/jnci/djx145 https://doi.org/10.1001/jamaoncol.2018.2487 https://www.ejim.ncgg.go.jp/pro/communication/c03/47.html 米国は1991年から国を挙げて30年以上研究しましたが、がんに効果のある代替医療は未だに見つかっていません https://en.wikipedia.org/wiki/National_Center_for_Complementary_and_Integrative_Health https://www.ejim.ncgg.go.jp/

Written by EE7192EF0B1C47D8A3430C3E070DA2A0BFAA58717F9133404318E9D7666B1A00
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1844200126178603176

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1844382579711148243
  • noteId - 1844382579711148243
  • participantId -
  • noteAuthorParticipantId - EE7192EF0B1C47D8A3430C3E070DA2A0BFAA58717F9133404318E9D7666B1A00 Participant Details
  • createdAtMillis - 1728570048632
  • tweetId - 1844200126178603176
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 1
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • 世界でも抗がん剤は沢山使われています https://news.yahoo.co.jp/expert/articles/1b191a2ed5889e97d4311826f130aa016629b2a8 https://answers.ten-navi.com/pharmanews/16470/ https://www.who.int/europe/news-room/fact-sheets/item/cancer-treatment 日本の年齢調整死亡率は減少しておりG7の中でも最も優秀です https://data.oecd.org/chart/7hLT https://data.oecd.org/healthstat/deaths-from-cancer.htm 米国国立がん研究所所長(当時)DeVita氏は、がん死亡減少の半分の原因は主に化学療法を含むがん治療の進歩によるとしています https://doi.org/10.1158/0008-5472.CAN-07-6611 https://en.wikipedia.org/wiki/Vincent_T._DeVita 科学的根拠に基づかない主張の目的は偽医療への誘導です。 日本人が欧米事情等に疎いことは昔から偽医療利権に悪用されます https://youtu.be/nySPY7eH9IU https://cancer.jpn.org/static/fake_medicine.html https://cancer.jpn.org/static/ota_h_405_unconventional_cancer_treatments.html 代替医療にがんの治療効果はありません https://doi.org/10.1093/jnci/djx145 https://doi.org/10.1001/jamaoncol.2018.2487 https://www.ejim.ncgg.go.jp/pro/communication/c03/47.html 米国は1991年から国を挙げて30年以上研究しましたが、がんに効果のある代替医療は未だに見つかっていません https://en.wikipedia.org/wiki/National_Center_for_Complementary_and_Integrative_Health https://www.ejim.ncgg.go.jp/

Note Ratings

rated at rated by
2024-10-11 06:08:49 -0500 Rating Details
2024-10-11 06:00:14 -0500 Rating Details
2024-10-11 05:45:16 -0500 Rating Details
2024-10-11 05:29:58 -0500 Rating Details
2024-10-11 03:59:06 -0500 Rating Details
2024-10-10 10:37:39 -0500 Rating Details
2024-10-10 10:21:14 -0500 Rating Details
2024-10-11 10:41:00 -0500 Rating Details
2024-10-11 06:29:38 -0500 Rating Details
2024-10-11 05:47:33 -0500 Rating Details
2024-10-11 05:32:54 -0500 Rating Details
2024-10-10 16:44:59 -0500 Rating Details
2024-10-10 11:18:40 -0500 Rating Details
2024-10-10 11:05:00 -0500 Rating Details
2024-10-10 10:05:54 -0500 Rating Details
2024-10-10 09:50:20 -0500 Rating Details
2024-10-11 19:40:12 -0500 Rating Details
2024-10-11 07:06:12 -0500 Rating Details
2024-10-11 06:38:26 -0500 Rating Details
2024-10-11 05:52:57 -0500 Rating Details
2024-10-11 05:32:54 -0500 Rating Details
2024-10-10 22:46:52 -0500 Rating Details
2024-10-10 18:33:11 -0500 Rating Details
2024-10-10 16:39:43 -0500 Rating Details
2024-10-10 10:16:32 -0500 Rating Details
2024-10-10 10:07:01 -0500 Rating Details
2024-10-10 09:27:38 -0500 Rating Details
2024-10-26 13:15:01 -0500 Rating Details
2024-10-11 17:16:00 -0500 Rating Details
2024-10-11 13:11:22 -0500 Rating Details
2024-10-11 06:07:44 -0500 Rating Details
2024-10-11 05:46:27 -0500 Rating Details
2024-10-11 05:29:02 -0500 Rating Details
2024-10-10 17:30:53 -0500 Rating Details
2024-10-10 11:59:53 -0500 Rating Details
2024-10-10 10:55:57 -0500 Rating Details
2024-10-10 10:04:01 -0500 Rating Details
2024-10-15 04:03:06 -0500 Rating Details
2024-10-11 19:43:18 -0500 Rating Details
2024-10-11 10:48:58 -0500 Rating Details
2024-10-11 06:23:57 -0500 Rating Details
2024-10-11 05:31:16 -0500 Rating Details
2024-10-11 05:27:50 -0500 Rating Details
2024-10-10 18:21:15 -0500 Rating Details
2024-10-10 17:50:35 -0500 Rating Details
2024-10-10 17:44:34 -0500 Rating Details
2024-10-10 10:28:17 -0500 Rating Details
2024-10-10 10:18:10 -0500 Rating Details
2024-10-10 10:07:43 -0500 Rating Details
2024-10-10 10:03:19 -0500 Rating Details
2024-10-10 10:02:56 -0500 Rating Details
2024-10-10 10:00:16 -0500 Rating Details
2024-10-10 09:45:12 -0500 Rating Details